MARLBOROUGH, Mass. — Akoya Biosciences Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced the appointment of diagnostics industry leader Scott Mendel to its board of directors. “I am delighted to join the board of directors of Akoya, a company that has the potential to transform biomarker discovery and clinical research through the application of […]
WELLESLEY, Mass. — Ampersand Capital Partners announced today that it has completed the sale of Nexcelom Bioscience, one of its portfolio companies and a leading provider of automated cell counting solutions, to PerkinElmer for $260 million in cash. Founded in 2003 and headquartered in Lawrence, Massachusetts, Nexcelom is the manufacturer of innovative Cellometer, Cellaca MX, and Celigo image cytometry […]
GUILFORD, Conn. — Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today that it has entered into a lease agreement with Phase 3 Real Estate Partners, Inc. to develop a 25,586-square-foot product development and operations facility in San Diego, CA. The new facility, located in Sorrento Mesa, is being designed to scale production […]
Broadened agreement includes the development of novel technologies for allogeneic CAR-NK cell expansion Catamaran also secures broad worldwide license to TcBuster™ transposon system for clinical and commercial manufacturing of next generation cell therapies MINNEAPOLIS, MN and CAMBRIDGE, MA – Bio-Techne Corporation (NASDAQ: TECH) and Catamaran Bio today announced an expansion of their collaboration for the […]
Virum, Denmark – Life Science Newswire – Immudex announces the launch of the new U-Load Dextramer® product line that allows scientists to swiftly assemble their own sensitive antigen-specific Dextramer® reagents for immune monitoring directly in the lab using loadable MHC class I easYmer® and the novel loadable MHC class II monomers, U-Load MHC II. Whether via flow cytometry […]
Florida, USA – BioTools, provider of instrumentation and analytical services for structure elucidation of biologics and chiral molecules for drug discovery, and Liverpool ChiroChem (LCC), a chemical technology innovator that produces thousands of novel, multifunctional 3D fragments/scaffolds/building blocks to support new chiral entities (NCE) discovery & development, announce a collaboration to determine the absolute configuration […]
We are delighted to have been awarded a grant of up to £320,000 from Innovate UK, the UK’s innovation agency, for the research and development of a 100L bioreactor for stem cell applications. Our existing range Our existing range of patented airlift, single-use bioreactors includes the CellMaker Systems: Regular, Low Flow and Plus – created […]
REDWOOD CITY, Calif. — GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of Britton Russell, Mary Stewart, and Surekha Karudapuram to its executive team. “We are pleased to welcome Britton, Mary, and Surekha to our growing team,” said Jason Myers, Ph.D., Chief Executive Officer of GenapSys. “Their deep set […]
SOUTH SAN FRANCISCO, Calif. — NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, enters the protein production market with the release of Andromeda, an instrument that determines optimal expression levels and thermal stability of recombinant membrane proteins in crude lysates — something unachievable using currently available methods or technologies on their own. […]
Modern Water enters Service Agreement with EPS Group for European Microtox® PD installations YORK, England — DeepVerge (LSE: DVRG.L), today announces the successful completion of Phase 3 field trials in which Microtox® PD achieved real-time detection and transmission of data, specific to SARS-CoV-2, in wastewater treatment plants at multiple sites. As a result, its Environmental Health Division […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
